Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT

Infinity Pharmaceuticals Company Description

Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer.

The company’s product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors.

Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with F.

Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Cambridge, Massachusetts.

On September 29, 2023, Infinity Pharmaceuticals, Inc. along with its affiliate, a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

The plan was later approved as Chapter 11 liquidation on March 7, 2024.

Infinity Pharmaceuticals, Inc.
CountryUnited States
Founded1995
IndustryBiotechnology
SectorHealthcare
Employees30
CEOSeth Tasker

Contact Details

Address:
1100 Massachusetts Avenue
Cambridge, Delaware 02138
United States
Phone617 453 1000
Websiteinfi.com

Stock Details

Ticker SymbolINFIQ
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS45665G3039
SIC Code2834

Key Executives

NamePosition
Dr. Lawrence E. Bloch J.D., M.D.Treasurer